-Reuters
MoonLake Immunotherapeutics Signs Development And Manufacturing Agreement With Vetter Pharma International GmbH
MoonLake Immunotherapeutics AG ((MoonLake, NASDAQ:MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has signed a Master Development